Cargando…
Dicer Suppresses Hepatocellular Carcinoma via Interleukin-8 Pathway
BACKGROUND: Elevated level of interleukin-8 (IL-8) promotes hepatocellular carcinoma (HCC) development and contributes to poor prognosis. Previously, we have proved that Dicer inhibits HCC progression. In this study, we evaluated the potential interaction between IL-8 and Dicer as well as their infl...
Autores principales: | Han, Xin, Wu, Jianhua, Sha, Ziyue, Lai, Ruixue, Shi, Jianfei, Mi, Lili, Yin, Fei, Guo, Zhanjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088407/ https://www.ncbi.nlm.nih.gov/pubmed/37056297 http://dx.doi.org/10.1177/11795549231161212 |
Ejemplares similares
-
Dicer Enhances Bevacizumab-Related Inhibition of Hepatocellular Carcinoma via Blocking the Vascular Endothelial Growth Factor Pathway
por: Wang, Cuiju, et al.
Publicado: (2021) -
Prognostic significance of Dicer expression in hepatocellular carcinoma
por: ZHANG, LI, et al.
Publicado: (2016) -
Nonsynonymous C1653T Mutation of Hepatitis B Virus X Gene Enhances Malignancy of Hepatocellular Carcinoma Cells
por: Zhang, Cuifang, et al.
Publicado: (2022) -
Dicer increases the indication for trastuzumab treatment in gastric cancer patients via overexpression of human epidermal growth factor receptor 2
por: Wu, Jianhua, et al.
Publicado: (2021) -
Variation in the Dicer and RAN Genes Are Associated with Survival in Patients with Hepatocellular Carcinoma
por: Kim, Mi Na, et al.
Publicado: (2016)